Market Insider

In this article

Engineers move a 350-volt battery pack to be installed in a Fedex Corp. Express General Motors Co. (GM) van at the VIA Motors Inc. facility in Orem, Utah, U.S. on Monday, Feb. 17, 2014.
George Frey | Bloomberg | Getty Images

Here are the stocks making headlines after the bell.

FedEx — Shares of the shipping company rose more than 3% after FedEx issued upbeat guidance for its full fiscal year, projecting a rise in adjusted earnings. FedEx reported mixed results for its recently completed fiscal fourth quarter, with $6.87 in adjusted earnings per share on $24.39 billion of revenue. Analysts surveyed by Refinitiv were expecting $6.86 in earnings per share on $24.56 billion of revenue.

Sarepta Therapeutics — The biopharma stock dropped more than 5% in extended trading after the FDA placed a clinical hold on Sarepta’s treatment for Duchenne muscular dystrophy. Sarepta said there was a “serious adverse event” in one of the studies for the treatment.

Smith & Wesson Brands — Shares of the firearms manufacturer dipped about 2% after Smith & Wesson’s fiscal fourth-quarter report showed a year over year decline in revenue and gross margin. The company, which has a market cap of roughly $650 million, hiked its quarterly divided to 10 cents per share from 8 cents.

Articles You May Like

Nuclear Energy Stocks Could Be the Smartest AI Play for 2025
An Outperforming Investment Tool to Help You Game the Market
3 More Cyclical Stocks to Buy for 2025 
Power stocks plunge as energy needs called into question because of new China AI lab
DoubleLine’s Gundlach says his base case is one rate cut this year, two reductions maximum